| Gene symbol | STMN1 | Synonyms | C1orf215, LAP18, Lag, OP18, PP17, PP19, PR22, SMN | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.11 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | stathmin 1 | ||||
| GTO ID | GTC1407 |
| Trial ID | NCT01505153 |
| Disease | Metastatic Cancer | Solid Tumor |
| Altered gene | STMN1 |
| Therapeutic/Target gene | Target gene |
| Therapy | shRNA |
| Treatment | pbi-shRNA STMN1 LP |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer |
| Year | 2012 |
| Country | United States |
| Company sponsor | Gradalis, Inc. |
| Other ID(s) | CL-PTL 103 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||